Venus Remedies bags UBM India Pharma Award for Elores

04 Dec 2013 Evaluate

Venus Remedies has bagged the UBM India Pharma Award for its flagship product, Elores, in the Excellence in Product Development category. The award was presented at a glittering ceremony in Mumbai on December 2. This is the second award for Elores in the first year of its launch, and the company is expecting this product to generate a revenue of around $100 million by 2017-18.

Launched in January this year, Elores is a novel antibiotic adjuvant entity that effectively counters serious hospital-acquired infections caused by multidrug-resistant extended-spectrum beta-lactamase (ESBL) and metallo-beta-lactamase (MBL)-producing gram negative bacteria.

UBM is a leading service provider for all global events-led marketing and communications business. The award ceremony recognized select, path-breaking initiatives undertaken by the pharmaceutical industry in key areas of quality, product design, cost management, packaging, corporate social responsibility and research & development.

Venus Remedies Share Price

292.05 -7.85 (-2.62%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.